Search Results

There are 6091 results for: content related to: Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy

  1. Photodynamic therapy for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Richard Wormald, Jennifer R Evans, Liam L Smeeth and Katherine S Henshaw

    Published Online : 18 JUL 2007, DOI: 10.1002/14651858.CD002030.pub3

  2. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration

    Intervention Review

    The Cochrane Library

    Satyanarayana S Vedula and Magdalena Krzystolik

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD005139.pub2

  3. Clinical Pharmacokinetics of Verteporfin

    The Journal of Clinical Pharmacology

    Volume 42, Issue 5, May 2002, Pages: 547–557, Dr. Jean-Marie Houle and Andrew Strong

    Article first published online : 8 MAR 2013, DOI: 10.1177/00912700222011607

  4. You have free access to this content
    Combination of Phosphatidylinositol 3-Kinases Pathway Inhibitor and Photodynamic Therapy in Endothelial and Tumor Cells

    Photochemistry and Photobiology

    Volume 88, Issue 5, September/October 2012, Pages: 1265–1272, Babasola Fateye, Weihua Li, Chenguang Wang and Bin Chen

    Article first published online : 21 MAY 2012, DOI: 10.1111/j.1751-1097.2012.01160.x

  5. Comparative study of the phototoxicity of two chrolin type photosensitizers, ATX-S10(Na) and verteporfin, on vascular endothelial and retinal pigment epithelial cells

    Lasers in Surgery and Medicine

    Volume 34, Issue 3, March 2004, Pages: 216–226, Yufang Huang, Akira Obana, Yuko Gohto and Susumu Nakajima

    Article first published online : 5 MAR 2004, DOI: 10.1002/lsm.10251

  6. Photobleaching Kinetics of Optically Trapped Multilamellar Vesicles Containing Verteporfin Using Two-photon Excitation

    Photochemistry and Photobiology

    Volume 82, Issue 1, January 2006, Pages: 152–157, Kimberley S. Samkoe, Matthew S. Fecica, Rebecca L. Goyan, Jennifer L. Buchholz, Chantel Campbell, Nicole M. Kelly and David T. Cramb

    Article first published online : 30 APR 2007, DOI: 10.1562/2005-05-28-RA-549

  7. You have full text access to this OnlineOpen article
    New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence

    Acta Ophthalmologica Scandinavica

    Volume 85, Issue 1, February 2007, Pages: 6–20, Gianni Virgili, Diana V. Do, Neil M. Bressler and Ugo Menchini

    Article first published online : 22 JUN 2006, DOI: 10.1111/j.1600-0420.2006.00711.x

  8. You have full text access to this OnlineOpen article
    Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications and pharmacoeconomic properties

    Acta Ophthalmologica

    Volume 87, Issue 2, March 2009, Pages: 118–132, Alan F. Cruess, Gergana Zlateva, Andreas M. Pleil and Barbara Wirostko

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1755-3768.2008.01218.x

  9. Photodynamic Therapy–Induced Angiogenic Signaling: Consequences and Solutions to Improve Therapeutic Response

    Israel Journal of Chemistry

    Volume 52, Issue 8-9, September 2012, Pages: 681–690, Shannon M. Gallagher-Colombo, Amanda L. Maas, Min Yuan and Theresa M. Busch

    Article first published online : 30 JUL 2012, DOI: 10.1002/ijch.201200011

  10. New treatments in age-related macular degeneration

    Clinical & Experimental Ophthalmology

    Volume 31, Issue 5, October 2003, Pages: 376–391, Claire Y Hooper and Robyn H Guymer

    Article first published online : 26 SEP 2003, DOI: 10.1046/j.1442-9071.2003.00683.x

  11. You have full text access to this OnlineOpen article
    Treatment of age-related macular degeneration

    Clinical and Experimental Optometry

    Volume 88, Issue 5, September 2005, Pages: 322–334, Guy W. Bylsma and Robyn H. Guymer

    Article first published online : 26 FEB 2010, DOI: 10.1111/j.1444-0938.2005.tb06716.x

  12. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines

    Lasers in Surgery and Medicine

    Volume 43, Issue 7, September 2011, Pages: 565–574, Jonathan P. Celli, Nicolas Solban, Alvin Liang, Stephen P. Pereira and Tayyaba Hasan

    Article first published online : 23 AUG 2011, DOI: 10.1002/lsm.21093

  13. Photobleaching Kinetics of Verteporfin and Lemuteporfin in Cells and Optically Trapped Multilamellar Vesicles Using Two-photon Excitation

    Photochemistry and Photobiology

    Volume 87, Issue 4, July/August 2011, Pages: 853–861, Amy D. Tekrony, Nicole M. Kelly, B. Alexander Fage and David T. Cramb

    Article first published online : 9 MAY 2011, DOI: 10.1111/j.1751-1097.2011.00933.x

  14. You have full text access to this OnlineOpen article
    Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration

    Acta Ophthalmologica

    Volume 89, Issue 6, September 2011, Pages: 585–590, Ute E. K. Wolf-Schnurrbusch, Christian K. Brinkmann, Lisa Berger and Sebastian Wolf

    Article first published online : 30 OCT 2009, DOI: 10.1111/j.1755-3768.2009.01747.x

  15. Age-Related Macular Degeneration

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt061

  16. You have full text access to this OnlineOpen article
    Ranibizumab for the treatment of neovascular AMD

    International Journal of Clinical Practice

    Volume 61, Issue 3, March 2007, Pages: 501–509, P. K. Kaiser and D. V. Do

    Article first published online : 14 FEB 2007, DOI: 10.1111/j.1742-1241.2007.01299.x

  17. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study

    Clinical & Experimental Ophthalmology

    Volume 35, Issue 1, January/February 2007, Pages: 24–31, Dianne M Sharp, Susannah Lai and Caroline M Markey

    Article first published online : 7 FEB 2007, DOI: 10.1111/j.1442-9071.2007.01394.x

  18. Combination Therapy Using Verteporfin and Ranibizumab; Optimizing the Timing in the CAM Model

    Photochemistry and Photobiology

    Volume 85, Issue 6, November/December 2009, Pages: 1400–1408, Elodie Debefve, Bernadette Pegaz, Jean-Pierre Ballini and Hubert Van Den Bergh

    Article first published online : 5 AUG 2009, DOI: 10.1111/j.1751-1097.2009.00604.x

  19. Photodynamic therapy in practice: a review of the results of the first 12 months experience with verteporfin at the Royal Victorian Eye and Ear Hospital

    Clinical & Experimental Ophthalmology

    Volume 31, Issue 6, December 2003, Pages: 476–481, Rohan W Essex, Salmaan H Qureshi, Melinda S Cain, C Alex Harper and Robyn H Guymer

    Article first published online : 27 NOV 2003, DOI: 10.1046/j.1442-9071.2003.00714.x

  20. You have free access to this content
    Anti-vascular endothelial growth factor for myopic choroidal neovascularization

    Clinical & Experimental Ophthalmology

    Volume 40, Issue 1, January/February 2012, Pages: e98–e110, Danny S Ng, Alvin KH Kwok and Clement W Chan

    Article first published online : 5 FEB 2012, DOI: 10.1111/j.1442-9071.2011.02684.x